Anexinet’s Cloud Leader Ned Bellavance Receives Microsoft® Cloud and Datacenter MVP Award
Nov 08, 2017 12:01 pm UTC| Business
PHILADELPHIA, Nov. 08, 2017 -- Anexinet Corporation, a leading provider of analytics, digital and cloud solutions, today announced that Ned Bellavance, Director of Cloud Solutions, has been honored by Microsoft as a...
Nov 08, 2017 12:01 pm UTC| Business
ALPHARETTA, Ga., Nov. 08, 2017 -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today reported...
Assembly Biosciences to Present at the Jefferies London Healthcare Conference
Nov 08, 2017 12:01 pm UTC| Business
INDIANAPOLIS, Nov. 08, 2017 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel...
Kamada to Announce Third Quarter 2017 Financial Results and Host Conference Call on November 13
Nov 08, 2017 12:01 pm UTC| Business
REHOVOT, Israel, Nov. 08, 2017 -- Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today that it will release financial results for the third...
Quest Resource Welcomes Ric Hobby as Senior Vice President of Sales
Nov 08, 2017 12:01 pm UTC| Business
THE COLONY, Texas, Nov. 08, 2017 -- Quest Resource Holding Corporation (Nasdaq:QRHC) (“Quest”), a leader in sustainability, recycling, and environmental services, announced today that its wholly owned subsidiary, Quest...
Chimerix Announces Third Quarter 2017 Financial Results
Nov 08, 2017 12:01 pm UTC| Business
DURHAM, N.C., Nov. 08, 2017 -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today reported financial results and provided a corporate update for the...
Nov 08, 2017 12:01 pm UTC| Business
Granted QIDP designation for uncomplicated Urinary Tract Infections (uUTI) by the FDA Highlighted prelaunch activities during Investor Day presentations in October BOSTON, Nov. 08, 2017 -- Paratek Pharmaceuticals,...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update